Despite Recent Layoffs, Biotechnology Industry Is Far From Dead

Assessing the biotechnology industry based on layoffs alone is misleading. While statistics related to layoffs make the headlines and certainly have serious consequences for the affected individuals, numerous other factors need to be considered in order to characterize what is happening within the industry. Overall, while 1994 represented an all-time high in the number of biotechnology companies, as well as in the number of employees, some indications point to a reversal of the upward trend. F

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Assessing the biotechnology industry based on layoffs alone is misleading. While statistics related to layoffs make the headlines and certainly have serious consequences for the affected individuals, numerous other factors need to be considered in order to characterize what is happening within the industry.

Overall, while 1994 represented an all-time high in the number of biotechnology companies, as well as in the number of employees, some indications point to a reversal of the upward trend. For example, many analysts predict consolidation within the biotechnology industry (see story on page 1). Some industry watchers predict that within five years, half as many companies will exist. A key question for scientists is: If this comes to pass, will having half the number of com- panies mean half the number of jobs? Or will the number of jobs remain the same or increase within a smaller number of companies? There are several factors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eleanor Babco

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours